BSE filing, NSE: FORTIS. Summary written from the filing by ALFA Finder's alert engine.
Fortis Healthcare Ltd: key numbers
- Share price
- ₹759.50
- Market cap
- ₹57,339 Cr
- Revenue (annual)
- ₹9,128 Cr
- Net profit (annual)
- ₹1,042 Cr
- P/E (TTM)
- 54.7×Sector 52.0×
- Promoter holding
- 31.17%+0.00% QoQ
- FII holding
- 23.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fortis Healthcare Ltd
All →Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr
Fortis Healthcare Acquisition Worth ₹277 Cr
Fortis Healthcare's wholly-owned subsidiary IHL acquired Suguna Hospital's business and land in Bengaluru via slump sale. The cumulative consideration is approximately INR 277 Crore, consummated today.
- Value
- ₹277.0 Cr
Fortis Healthcare Acquisition Worth ₹1.85 Cr
Fortis Hospotel will acquire 26% of Clean Max Sau Pvt Ltd for ₹1.85 Crore. The SPV develops a captive solar project in Haryana for energy cost optimization.
- Value
- ₹1.85 Cr
- Execution
- Within 3 months of execution of the agreement
Fortis Healthcare Capacity Expansion: ₹1.85 Cr Investment
Subsidiary acquired 26% of an SPV for a captive solar project in Haryana. Investment of up to Rs. 1.85 Crore meets the company's green energy needs.
- Value
- ₹1.85 Cr
- Execution
- Within 3 months of execution of the agreement
Fortis Healthcare Debt & Borrowing
Fortis Healthcare files its half-yearly statement of listed debt securities as on September 30, 2026. Three NCD tranches maturing December 2029 remain outstanding with floating coupon rates.
Fortis Healthcare Legal & Regulatory
Northern TK Venture Pte Ltd, Fortis Healthcare's promoter, has appealed a Tokyo District Court judgment to the Tokyo High Court. The litigation concerns losses related to delayed tender offer approvals.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.